개선된 접합 방법 및 개선된 접합 방법으로 수득된 신규한 합성 올리고당-단백질 접합체
    1.
    发明公开
    개선된 접합 방법 및 개선된 접합 방법으로 수득된 신규한 합성 올리고당-단백질 접합체 审中-实审
    通过改进的缀合方法和改进的缀合方法获得的新型合成寡糖 - 蛋白质缀合物

    公开(公告)号:KR1020170065030A

    公开(公告)日:2017-06-12

    申请号:KR1020177012154

    申请日:2015-10-08

    摘要: 본발명은합성올리고당-단백질(OS-PR) 접합체를수득하기위한개선된접합방법에관한것이다. 합성 OS-PR 접합방법은높은면역원성을가지며특이적이고균질한면역반응을유도하는올리고당-단백질접합체를제공하는신속한방법이다. 합성올리고당은각 단량체의 4 내지 8개반복단량체단위및 적어도하나의내재된말단아미노링커를포함하며, 상기합성다당류는나이세리아메닝기티디스() 혈청그룹 A, C, Y, W, X 및헤모필루스인플루엔자()와같은그람음성세균으로부터수득되는천연다당류를모방하고, 캐리어단백질은클로스트리디움테타니((파상풍톡소이드) 또는코리네박테리움디프테리아((CRM197) 또는그들의재조합체와같은그람양성세균으로부터수득된다. 본발명의상기올리고당-단백질접합체의접합화학은티오-에테르연결이다. 본발명은 14 내지 22 시간의범위의완성공정시간을갖는다. 상기올리고당-단백질접합체는 1가백신또는다가혼합백신의제조및 진단도구로서유용하다.

    摘要翻译: 本发明涉及用于获得合成寡糖 - 蛋白质(OS-PR)缀合物的改良缀合方法。 合成OS-PR接合方法寡糖诱导特异性和均匀的免疫应答具有高免疫原性 - 提供蛋白缀合物的快速方法。 合成的低聚糖重复4至各单体的8包括单体单元和底层终端氨基接头中的至少一个,所述合成多糖老化系列美国转动GITI显示器()血清群A,C,Y,W,X和 仿真)从阴性菌如流感嗜血杆菌(衍生克天然多糖和载体蛋白是破伤风梭菌((破伤风类毒素)或白喉棒状杆菌((CRM197),或从革兰氏阳性细菌,如它们的重组 根据本发明获得的寡糖 - 结合蛋白缀合物的化学是硫代 - 本发明已经完成了处理时间为14至22倍的寡糖 - 蛋白质结合物是单价疫苗或多价疫苗的醚连接 作为诊断和诊断工具很有用。

    정전형 변환기를 가지는 이어폰
    4.
    发明公开
    정전형 변환기를 가지는 이어폰 有权
    带静电传感器的耳机

    公开(公告)号:KR1020150052218A

    公开(公告)日:2015-05-13

    申请号:KR1020157008440

    申请日:2013-07-30

    摘要: 클로즈드백하우징(102), 외이도를음향적으로밀봉하기위한슬리브(108), 및정전형변환기(214)를가지는정전형이어폰이제공된다. 클로즈드백하우징은외이도를향한음향의음향적전송을위한노즐(106)을포함할수 있고슬리브(108)는노즐(106)에분리가능하게부착될수 있다. 정전형변환기(214)는전도층을갖는다이아프램(308), 고정자판들(304A, 304B), 및다이아프램(308)의전도층과전기적으로접촉된다이아프램고리들(402A, 402B)을포함할수 있다. 고정자판들(304A, 304B)은외부환형전도부및 중심전도부를포함할수 있다. 외부환형부는바이어스전압및 다이아프램고리들(402A, 402B)과전기적으로접촉될수 있다. 중심전도부는유전층을가질수 있고, 오디오신호와전기적으로접촉될수 있다. 고정자판들(304A, 304B) 및다이아프램(308)은다이아프램고리들(402A, 402B)에의해서로떨어져있을수 있다. 증폭기는이어폰에바이어스전압과오디오신호를제공할수 있다.

    摘要翻译: 提供具有闭合外壳的静电耳机,用于声学地密封到耳道的套筒和静电换能器。 封闭式壳体可以包括用于将声音传播到耳道的喷嘴,并且套筒可以可移除地附接到喷嘴。 静电换能器可以包括具有与隔膜的导电层电接触的导电层,定子板和隔膜环的隔膜。 定子板可以包括外环形导电部分和中心导电部分。 外环形部分可以与偏置电压电接触并且隔膜环。 中心部分可以具有电介质层并与音频信号电接触。 定子板和隔膜可以通过隔膜环隔开。 放大器可以向耳机提供偏置电压和音频信号。

    전분-식물성 오일 이식 공중합체와 이들의 바이오섬유복합물 및 이들의 제조 공정
    6.
    发明公开
    전분-식물성 오일 이식 공중합체와 이들의 바이오섬유복합물 및 이들의 제조 공정 无效
    淀粉 - 油菜籽共聚物及其生物复合材料及其生产工艺

    公开(公告)号:KR1020060115648A

    公开(公告)日:2006-11-09

    申请号:KR1020060040250

    申请日:2006-05-04

    IPC分类号: C08L3/02 C08L3/00 C08H99/00

    摘要: Provided is a starch-vegetable oil graft copolymer, which has excellent processability and mechanical properties, and produces a composite suitable for injection molding into biodegradable articles when reinforced with biofiber. The biodegradable starch-vegetable oil graft copolymer composition comprises: granular starch; vegetable oil or a derivative thereof containing a modifier reactive to the starch; and a hydroxylated plasticizer. The granular starch includes corn starch, potato starch, tapioca starch, rice starch, wheat starch, cassava starch or high-amylose corn starch. The starch is present in an amount of 5-90 wt% based on the total weight of the composition.

    摘要翻译: 提供了一种淀粉 - 植物油接枝共聚物,其具有优异的加工性能和机械性能,并且当用生物纤维增强时,产生适于注射成型为可生物降解制品的复合材料。 可生物降解的淀粉 - 植物油接枝共聚物组合物包括:颗粒淀粉; 含有与淀粉反应的改性剂的植物油或其衍生物; 和羟基化增塑剂。 颗粒淀粉包括玉米淀粉,马铃薯淀粉,木薯淀粉,大米淀粉,小麦淀粉,木薯淀粉或高直链淀粉玉米淀粉。 基于组合物的总重量,淀粉的存在量为5-90重量%。

    하이드록시알킬 전분 유도체의 제조 방법
    7.
    发明公开
    하이드록시알킬 전분 유도체의 제조 방법 失效
    生产羟基烷基淀粉衍生物的方法

    公开(公告)号:KR1020050061466A

    公开(公告)日:2005-06-22

    申请号:KR1020057003902

    申请日:2003-08-08

    IPC分类号: C08B31/12 C08B31/00 C08B31/10

    摘要: The present invention relates to a method of producing a hydroxyalkyl starch derivative, said hydroxyalkyl starch having a structure according to formula (I) comprising reacting - hydroxyalkyl starch o formula (I) at its optionally oxidized reducing end or - a hydroxyalkyl starch derivative, obtainable by reacting hydroxyalkyl starch of formula (I) at its optionally oxidized reducing end with a compound (D), said compound (D) comprising - at least one functional group Z1 capable of being reacted with the optionally oxidized reducing end of the hydroxyalkyl starch, and at least one functional group W, with a compound (L) comprising at least one functional group Z1 capable of being reacted with said hydroxyalkyl starch, or at least one functional group Z2 capable of being reacted with functional group W comprised in said hydroxyalkyl starch derivative, and at least one functional group X capable of being reacted with a functional group Y of a further compound (M), wherein said functional group Y is selected from the group consisting of an aldehyd group, a keto group, a hemiacetal group, an acetal group, and a thio group. The present invention further relates to the hydroxyalkyl starch derivatives as such ans a pharmaceutical composition comprising the hydroxyalkyl starch derivatives.

    摘要翻译: 本发明涉及一种生产羟烷基淀粉衍生物的方法,所述羟烷基淀粉具有根据式(I)的结构,包括在其任意氧化的还原性末端反应式(I)羟烷基淀粉或可得到的羟烷基淀粉衍生物 通过使式(I)的羟烷基淀粉在其任选被氧化的还原端与化合物(D)反应,所述化合物(D)包含至少一个能够与任选氧化的羟烷基淀粉的还原端反应的官能团Z1, 和至少一个官能团W,其中化合物(L)包含至少一个能够与所述羟烷基淀粉反应的官能团Z1,或至少一个能够与所述羟烷基淀粉中包含的官能团W反应的官能团Z2 衍生物和至少一种能够与其它化合物(M)的官能团Y反应的官能团X,其中所述官能团 Y组选自醛基,酮基,半缩醛基,缩醛基和硫基。 本发明还涉及这样的羟烷基淀粉衍生物和包含羟烷基淀粉衍生物的药物组合物。

    무세포성적혈구대체물을제조하기위한방법및장치
    8.
    发明公开
    무세포성적혈구대체물을제조하기위한방법및장치 失效
    用于制备细胞红血球细胞替代物的方法和装置

    公开(公告)号:KR1020000005058A

    公开(公告)日:2000-01-25

    申请号:KR1019980707685

    申请日:1997-03-27

    IPC分类号: C07K14/805

    摘要: PURPOSE: A hemoglobin substitute and a preparation method thereof are provided, which has half life more than 15 hours when administered to human and no toxicity. CONSTITUTION: The hemoglobin substitute is free from tetramer, stroma and any toxic contaminating material, polymerized and pyridoxylated. Also the hemoglobin substitute is free from white blood cells and platelets. Preferably the hemoglobin substitute is glutaraldehyde-polymerized hemoglobin. The hemoglobin substitute is prepared by removing white blood cells and platelets from a blood; washing and performing the lysis of blood red cells; removing stroma and stroma contaminating material by filtration and heating; preparing hemoglobin in oxygen-free state; pyridoxylating and polymerizing it; purifying and concentrating it further; and deoxygenizing it at about 10-12°C to make the content of oxyhemoglobin below about 16 wt% based on the weight of the total hemoglobin.

    摘要翻译: 目的:提供血红蛋白替代物及其制备方法,其给予人体的半衰期超过15小时,无毒性。 构成:血红蛋白替代物不含四聚体,基质和任何有毒的污染物质,被聚合和吡哆醛化。 血红蛋白替代物也不含白细胞和血小板。 优选地,血红蛋白替代物是戊二醛聚合的血红蛋白。 通过从血液中除去白细胞和血小板制备血红蛋白替代品; 洗涤并进行红细胞溶解; 通过过滤和加热去除基质和基质污染物质; 在无氧状态下制备血红蛋白; 吡哆醛化并使其聚合; 进一步净化和浓缩; 并在约10-12℃下将其脱氧以使氧合血红蛋白的含量基于总血红蛋白的重量低于约16重量%。